Red Blood Cell Morphologic Abnormalities in Patients Hospitalized for COVID-19.
COVID-19
RBC morphology
erythrocyte membrane
peripheral blood smear
red blood cells (RBCs)
Journal
Frontiers in physiology
ISSN: 1664-042X
Titre abrégé: Front Physiol
Pays: Switzerland
ID NLM: 101549006
Informations de publication
Date de publication:
2022
2022
Historique:
received:
29
04
2022
accepted:
14
06
2022
entrez:
21
7
2022
pubmed:
22
7
2022
medline:
22
7
2022
Statut:
epublish
Résumé
Peripheral blood smear is a simple laboratory tool, which remains of invaluable help for diagnosing primary and secondary abnormalities of blood cells despite advances in automated and molecular techniques. Red blood cells (RBCs) abnormalities are known to occur in many viral infections, typically in the form of mild normo-microcytic anemia. While several hematological alterations at automated complete blood count (including neutrophilia, lymphopenia, and increased red cell distribution width-RDW) have been consistently associated with severity of COVID-19, there is scarce information on RBCs morphological abnormalities, mainly as case-reports or small series of patients, which are hardly comparable due to heterogeneity in sampling times and definition of illness severity. We report here a systematic evaluation of RBCs morphology at peripheral blood smear in COVID-19 patients within the first 72 h from hospital admission. One hundred and fifteen patients were included, with detailed collection of other clinical variables and follow-up. A certain degree of abnormalities in RBCs morphology was observed in 75 (65%) patients. Heterogenous alterations were noted, with spiculated cells being the more frequent morphology. The group with >10% RBCs abnormalities had more consistent lymphopenia and thrombocytopenia compared to those without abnormalities or <10% RBCs abnormalities (
Identifiants
pubmed: 35860651
doi: 10.3389/fphys.2022.932013
pii: 932013
pmc: PMC9289213
doi:
Types de publication
Journal Article
Langues
eng
Pagination
932013Informations de copyright
Copyright © 2022 Marchi, Bozzini, Bertolone, Dima, Busti, Castagna, Stranieri, Fratta Pasini, Friso, Lippi, Girelli and Vianello.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Clin Chim Acta. 2020 Sep;508:122-129
pubmed: 32417210
Br J Haematol. 2021 Jan;192(2):230
pubmed: 33399215
Semin Hematol. 2021 Jul;58(3):182-187
pubmed: 34389110
Br J Haematol. 2020 May;189(3):438-441
pubmed: 32285448
Nat Med. 2021 Jan;27(1):28-33
pubmed: 33442016
Stem Cell Reports. 2021 May 11;16(5):1165-1181
pubmed: 33979601
Nat Commun. 2021 Mar 12;12(1):1645
pubmed: 33712594
N Engl J Med. 2005 Aug 4;353(5):498-507
pubmed: 16079373
Cell Mol Life Sci. 2022 Mar 13;79(3):187
pubmed: 35284964
Am J Physiol Lung Cell Mol Physiol. 2021 Aug 1;321(2):L485-L489
pubmed: 34231390
Am J Hematol. 2020 Aug;95(8):999-1000
pubmed: 32212392
Acta Haematol. 2021;144(4):360-364
pubmed: 32841949
Ann Transl Med. 2020 May;8(9):593
pubmed: 32566620
Antioxidants (Basel). 2021 Oct 25;10(11):
pubmed: 34829548
Clin Exp Med. 2021 May;21(2):239-246
pubmed: 33417082
J Proteome Res. 2020 Nov 6;19(11):4455-4469
pubmed: 33103907
Pathol Res Pract. 2022 Mar;231:153782
pubmed: 35121363
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
J Leukoc Biol. 2021 Jan;109(1):13-22
pubmed: 33040384
Biophys J. 2021 Jul 20;120(14):2838-2847
pubmed: 34087216
Rev Med Virol. 2022 Mar;32(2):e2264
pubmed: 34091982
Am J Clin Pathol. 2020 Aug 5;154(3):319-329
pubmed: 32756872
J Clin Pathol. 2021 Nov;74(11):750-751
pubmed: 33067181
Blood. 2020 Aug 6;136(6):766-768
pubmed: 32559762
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3
pubmed: 32320677
Blood Transfus. 2021 Jan;19(1):34-36
pubmed: 32955421
PLoS One. 2020 Nov 17;15(11):e0241955
pubmed: 33201896
Br J Haematol. 2021 May;193(3):481
pubmed: 33427300
N Engl J Med. 2019 Sep 19;381(12):1148-1157
pubmed: 31532961